Completed EARLY_PHASE1 INTERVENTIONAL 8-arm NCT03039491

Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults

Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals

Sponsor: Medical University of South Carolina

Interventions 13 valent conjugated pneumococcal vaccine Pneumococcal polysaccharide vaccine 23 valent

Updated 8 times since 2017 Last updated: Jun 12, 2020 Started: Sep 1, 2015 Primary completion: Mar 30, 2020 Completion: Mar 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03039491, this EARLY_PHASE1 trial focuses on Aging and HIV Lipodystrophy and remains completed. Sponsored by Medical University of South Carolina, it has been updated 8 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jul 2020 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
May 2019 — Jul 2020 [monthly]

Recruiting EARLY_PHASE1

▶ Show 3 earlier versions

Jul 2018 — May 2019 [monthly]

Recruiting EARLY_PHASE1
Jun 2018 — Jul 2018 [monthly]

Recruiting EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States